A Step-by-Step Guide to Cancer Genetic Testing

Article

Dr. Ami P. Vaidya tells patients and their loved ones what to expect when they opt for cancer genetic testing.

genetic testing process

What to expect from genetic testing.

Genetic testing is key in determining cancer treatments and family members’ potential risk for disease development. However, after an individual decides that they will undergo testing, they may not know what to expect.

In a recent interview with CURE®, Dr. Ami P. Vaidya, co-chief of the division of gynecologic oncology and vice chair in the department of Obstetrics and Gynecology at Hackensack Meridian Health University Medical Center, outlined the process and encouraged people to undergo genetic testing if they are eligible.

Genetic Testing Process

The process will start with a consultation, either with a genetic counselor or a member from the oncology care team. Family history will be collected, including family members’ cancer history and what age they were diagnosed.

Then, individuals will likely have blood drawn – though some tests allow for a buccal swab that is collected from the inside of the cheek. “So, there are two ways to do testing, both of which I’d say are minimally invasive,” Vaidya said.

Then, the sample is tested, where experts look for various genetic mutations that can be associated with an increased cancer risk or help decide treatment options for someone who already received a diagnosis.

“Test results are then processed and run in the various labs. Typically, turnaround times that we see are about two weeks, where a very detailed report is generated,” Vaidya said, explaining that the next step is another consultation where the results are explained to the patient or family member.

Paying for Testing

With a process that is so involved, patients and their loved ones may be concerned about the cost of cancer genetic testing – especially since these tests carried a hefty price tag in years past.

However, the cost of genetic testing has drastically decreased in recent years for patients and their relatives.

“There are so many (insurance) plans, and every plan is different, but I can say for the most part that the majority of plans – including Medicare and Medicaid plans – are covering what we call Cascade genetic testing,” Vaidya said, explaining that Cascade testing looks for a certain genetic mutation in the direct family member(s) of a patient with cancer who is known to have that mutation.

Even patients who do not have health insurance may be able to receive assistance in paying for genetic testing.

“Tests that were running in the thousands of dollars are now in the hundreds of dollars (price range), so it’s really a quite dramatic change in price,” Vaidya said. “Cascade testing is one of the places where we can really make a huge, positive impact. So (genetic testing companies) are very, very much willing to work with individuals – especially those who do not have insurance.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content